Press-release for stocks publishing date 2021 - 11

Prices are updated after-hours

HemoShear Therapeutics Identifies Second Novel Target to Treat NASH Through Successful Collaboration with Takeda
Published: 2021-11-16 (Crawled : 13:00) - biospace.com/
TAK | $13.215 0.49% 210K

| -9.0% | O: -0.9% H: 0.0% C: -1.47%
collaboration nash

Takeda’s Area Offices in Dubai, United Arab Emirates Certified Sustainable and Inaugurated
Published: 2021-11-16 (Crawled : 13:00) - globenewswire.com
TAK | $13.215 0.49% 210K

| -9.0% | O: -0.9% H: 0.0% C: -1.47%

83%

17%

AGBA | $0.7995 99.88% 73M

BPTH | $6.21 91.67% 58M

INVO | $1.36 78.95% 3.6M

TIRX | $0.8258 70.34% 50M

ISPC | $0.307 44.13% 3.6M

SINT | $0.0504 35.12% 300M

VTNR S | $1.295 32.25% 5.5M

ALRN | $5.53 30.12% 250K

SMSI 4 | $2.53 29.74% 510K

HOLO | $2.86 27.68% 28M

Save your searches and get alerts when important news are released.